COVID - 19 Vaccination Update - Day 522 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 41 Second

Posted On: 21 JUN 2022 8:09 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 196.44 Crore (1,96,44,19,344) today. More than 10 lakh (10,50,571) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10408393
	2^nd Dose	10057487
	Precaution Dose	5555077
FLWs	1^st Dose	18422337
	2^nd Dose	17613938
	Precaution Dose	9719136
Age Group 12-14 years	1^st Dose	35889183
	2^nd Dose	21488240
Age Group 15-18 years	1^st Dose	60155202
	2^nd Dose	47922386
Age Group 18-44 years	1^st Dose	557951226
	2^nd Dose	498491126
	Precaution Dose	2150320
Age Group 45-59 years	1^st Dose	203394772
	2^nd Dose	192795534
	Precaution Dose	2159433
Over 60 years	1^st Dose	127213192
	2^nd Dose	120381669
	Precaution Dose	22650693
Cumulative 1^st dose administered		1013434305
Cumulative 2^nd dose administered		908750380
Precaution Dose		42234659
Total		1964419344

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 21^st June, 2022 (522^nd Day)
HCWs	1^st Dose	30
	2^nd Dose	546
	Precaution Dose	12583
FLWs	1^st Dose	149
	2^nd Dose	782
	Precaution Dose	48045
Age Group 12-14 years	1^st Dose	59225
	2^nd Dose	171555
Age Group 15-18 years	1^st Dose	23025
	2^nd Dose	79749
Age Group 18-44 years	1^st Dose	25018
	2^nd Dose	278931
	Precaution Dose	60791
Age Group 45-59 years	1^st Dose	3543
	2^nd Dose	61592
	Precaution Dose	32976
Over 60 years	1^st Dose	3602
	2^nd Dose	42604
	Precaution Dose	145825
Cumulative 1^st dose administered		114592
Cumulative 2^nd dose administered		635759
Precaution Dose		300220
Total		1050571

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.